bioMérieux Share Price Euronext Paris
Equities
FR0010096479
Medical Equipment, Supplies & Distribution
Sales 2024 * | 3.9B 4.19B 350B | Sales 2025 * | 4.19B 4.51B 376B | Capitalization | 11.79B 12.68B 1,058B |
---|---|---|---|---|---|
Net income 2024 * | 467M 502M 41.89B | Net income 2025 * | 527M 567M 47.28B | EV / Sales 2024 * | 2.96 x |
Net cash position 2024 * | 263M 283M 23.63B | Net cash position 2025 * | 444M 477M 39.79B | EV / Sales 2025 * | 2.71 x |
P/E ratio 2024 * |
25.9
x | P/E ratio 2025 * |
22.9
x | Employees | - |
Yield 2024 * |
0.87% | Yield 2025 * |
1% | Free-Float | 36.21% |
Latest transcript on bioMérieux
Managers | Title | Age | Since |
---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 52 | 01/16/01 |
Chairman | 50 | 16/04/16 | |
Director of Finance/CFO | 47 | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 15/06/15 | |
Director/Board Member | 63 | 01/05/01 | |
Chairman | 50 | 16/04/16 |
1st Jan change | Capi. | |
---|---|---|
-1.68% | 8.37B | |
-1.22% | 5.4B | |
+21.74% | 5.27B | |
+1.03% | 4.63B | |
-54.00% | 3.13B | |
+13.22% | 2.77B | |
-8.47% | 2.25B | |
-0.46% | 1.95B | |
+22.56% | 1.79B |